RE: RE: BioFinance....July ? May be but I'm sure that there will be a milestone payment before July - this should confirm that data are ok - and maybe a second in July with the official data.
But there are only 105 patients in an open label. I'm sure that data are already well organised by the Committee which mission is to make sure that there is matter (efficacy / security) to continue the trial.
Two reasons to stay optimist:
- data from Phase I + II
- data showing that MCC is potent vs other types of cancer